MANAMA: Investcorp, a Bahrain-based alternative investment manager, has launched a new platform dedicated to investing in high-quality Chinese healthcare companies.
As part of this initiative, Investcorp has acquired minority equity stakes in Lu Daopei Medical Group and WeDoctor.
Terms of the transactions were not disclosed.
Founded in 2001 by hematology expert Dr Lu Daopei, Lu Daopei Medical Group (LDP) operates four hospitals across Beijing and Shanghai and is now the largest bone marrow transplant group for leukemia treatment in the world.
WeDoctor is an online healthcare services company founded in 2010 by artificial intelligence expert Jerry Liao. The company has more than 240 million registered users for its online appointment booking, prescription and diagnosis services.
Mohammed Alardhi, executive chairman of Investcorp, said, “The progress we have delivered on our expansion in Asia over the last two years has enabled us to take this significant next step in launching our first stand-alone investment platform in China. We believe that there are many attractive opportunities in the Chinese healthcare sector as this is a pivotal time to meet increasing demand for quality medical services and treatments.”
The new platform advances Investcorp’s Asia growth strategy and aims to create a highly curated portfolio of primary and secondary stakes in sector leading Chinese healthcare companies.
Hazem Ben-Gacem, co-chief executive of Investcorp, said, “We look forward to leveraging our resources and expertise in partnership with our portfolio companies to deliver exceptional care to patients and enhanced value for all of our stakeholders.”
&uuid=(email))